<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7500907\results\search\testTrace\results.xml">
  <result pre="aspects of drug therapy in patients with moderate to severe" exact="infection" post="GhasemiyehParisaabMohammadi-SamaniSolimanbcâ�Ž[a], [b], [c], â�ŽCorresponding author at: School of Pharmacy,"/>
  <result pre="predisposing diseases are highly prone to COVID-19 and manifesting severe" exact="infection" post="especially with organ function damage such as acute respiratory"/>
  <result pre="death. Till now many drugs have been considered in the" exact="treatment" post="of COVID-19 pneumonia, but pharmacotherapy in elderly patients and"/>
  <result pre="review, different potential drugs which have been considered in COVID-19" exact="treatment" post="have been discussed in detail. Also, challenges in the"/>
  <result pre="with underlying diseases are highly prone to present with severe" exact="infection" post="especially with organ function damage such as acute respiratory"/>
  <result pre="be touched with unwashed hands, regular surface disinfecting is required," exact="social distancing" post="from people with respiratory symptoms is essential, sneezing or"/>
  <result pre="done into the elbow or soft tissue if available.16 COVID-19" exact="diagnosis" post="Based on the published reports, in most of the"/>
  <result pre="Laboratory confirmation of steatosis could be performed by real-time reverse-transcription" exact="polymerase chain reaction" post="(rRT-PCR).20,21 According to WHO approved laboratory testing for COVID-19"/>
  <result pre="reverse-transcription polymerase chain reaction (rRT-PCR).20,21 According to WHO approved laboratory" exact="testing" post="for COVID-19 diagnosis is based on nucleic acid amplification"/>
  <result pre="reaction (rRT-PCR).20,21 According to WHO approved laboratory testing for COVID-19" exact="diagnosis" post="is based on nucleic acid amplification test (NAAT) such"/>
  <result pre="COVID-19.22 Non-pharmacotherapy interventions Governments need to appreciate people to obey" exact="social distancing" post="and isolation. In some situations, quarantine of major cities"/>
  <result pre="people to obey social distancing and isolation. In some situations," exact="quarantine" post="of major cities is also suggestive. Global health governance"/>
  <result pre="could be an alternative agent with identical effects in the" exact="treatment" post="of COVID-19 pneumonia.39 750 mg of chloroquine is equal"/>
  <result pre="the efficacy of hydroxychloroquine or chloroquine on the prevention or" exact="treatment" post="of COVID-19 revealed that the available evidences on their"/>
  <result pre="of total adverse effects in comparison to placebo or no" exact="treatment" post="(control group) in overall population of patients with COVID-19.45"/>
  <result pre="recommended during drug administration.46 Chloroquine/Hydrpxychloroquine mechanism of action in coronavirus" exact="treatment" post="Recently published studies revealed that chloroquine could highly reduce"/>
  <result pre="twice daily. The most important advantage of chloroquine in COVID-19" exact="treatment" post="is good penetration to tissues especially lungs which are"/>
  <result pre="are highly affected in COVID-19 pneumonia. Chloroquine could stop viral" exact="infection" post="by enhancing the pH of endosomes which is required"/>
  <result pre="would be a better option in pregnant women with COVID-19" exact="infection" post="because of its safety profile during pregnancy.38 Lactation According"/>
  <result pre="entrance to targeted cells.54 Umifenovir mechanism of action in coronavirus" exact="treatment" post="Umifenovirhas a dual pharmacologic action: First is its beneficial"/>
  <result pre="2004, umifenovir was patented for its beneficial effect in the" exact="treatment" post="of severe acute respiratory distress (SARS) coronavirus-induced atypical pneumonia.55"/>
  <result pre="direct-acting antiviral (DAA) agent.56 Ribavirin mechanism of action in coronavirus" exact="treatment" post="Ribavirin is a nucleoside analog that has antiviral action"/>
  <result pre="in children with COVID-19.27 Lopinavir/Ritonavir mechanism of action in coronavirus" exact="treatment" post="Lopinavir/ritonavir are protease inhibitor, anti-retroviral agents. The potential antiviral"/>
  <result pre="the critical role of IL-6 in the hyper-inflammatory state after" exact="infection" post="with COVID-19, so the blockers of IL-6 would be"/>
  <result pre="results, teicoplanin would be a promising alternative in COVID-19 pneumonia" exact="treatment" post="but further randomized clinical trials are required to confirm"/>
  <result pre="Administration (FDA) approved the emergency use of remdesivir for the" exact="treatment" post="of suspected or confirmed COVID-19 patients both in adults"/>
  <result pre="COVID-19 complications and WHO in the recent guideline in the" exact="treatment" post="of COVID-19 advice against the use of corticosteroids.68 Dexamethasone"/>
  <result pre="are controversial comments on the usage of NSAIDs in the" exact="treatment" post="of COVID-19. A possible disadvantage of NSAIDs such as"/>
  <result pre="A possible disadvantage of NSAIDs such as Ibuprofen in COVID-19" exact="infection" post="is their potential effects in over-expression of ACE2 and"/>
  <result pre="of NSAIDs is their masking effect which can delay the" exact="diagnosis" post="of COVID-19 infection.68 Favipiravir Favipiravir, a guanine analog, is"/>
  <result pre="patients. Previous results revealed that convalescent plasma therapy during viral" exact="infection" post="outbreaks, could improve patientsâ€™ survival rate, shorten the duration"/>
  <result pre="therapy should be done at the early stages of COVID-19" exact="infection" post="to reach its most efficacy. According to the recent"/>
  <result pre="recovered from COVID-19 would be a promising option in COVID-19" exact="infection" post="treatment. This approach has been considered safe with no"/>
  <result pre="required and no evidence of pneumonia. In this group, antiviral" exact="treatment" post="is not required. They should be managed with supportive"/>
  <result pre="number of COVID-19 deaths were associated with cardiovascular diseases. COVID-19" exact="infection" post="could act as a precipitating factor in patients with"/>
  <result pre="and myocardial ischemia have occurred. In cases with ACS, COVID-19" exact="infection" post="could deteriorate patientsâ€™ condition and lead to death. Coronary"/>
  <result pre="Most of the hepatic metabolites of drugs considered in COVID-19" exact="treatment" post="such as chloroquine, hydroxychloroquine, and lopinavir/ritonavir would be found"/>
  <result pre="and ALT serum levels) have been occurred after and during" exact="infection" post="with COVID-19. These abnormalities would be related to viral"/>
  <result pre="infection with COVID-19. These abnormalities would be related to viral" exact="infection" post="pathogenesis and direct liver injury or it may be"/>
  <result pre="be drug-induced.88 Almost all of the potential drugs in COVID-19" exact="treatment" post="containing chloroquine, hydroxychloroquine, ribavirin, and lopinavir/ritonavir have hepatic metabolism."/>
  <result pre="pneumonia. Till now many drugs have been considered in the" exact="treatment" post="of COVID-19 pneumonia, but pharmacotherapy in patients with pre-existing"/>
  <result pre="review, different potential drugs which have been considered in COVID-19" exact="treatment" post="have been discussed in detail. Also, challenges in the"/>
  <result pre="those who are ACEIs consumers should be highly considered in" exact="treatment" post="options. Also, patients with liver and kidney disease and"/>
  <result pre="disease (COVID-19) outbreakJ Autoimmun2020102433 13WangTDuZZhuFCaoZAnYGaoYComorbidities and multi-organ injuries in the" exact="treatment" post="of COVID-19The Lancet395102282020e52 14XuZShiLWangYZhangJHuangLZhangCPathological findings of COVID-19 associated with"/>
  <result pre="21LanLXuDYeGXiaCWangSLiYPositive RT-PCR test results in patients recovered from COVID-19JAMA2020 22OrganizationWH.Laboratory" exact="testing" post="for coronavirus disease 2019 (COVID-19) in suspected human cases:"/>
  <result pre="mortalityInt J Antimicrob Agents2020105954 31BaronSADevauxCColsonPRaoultDRolainJ-MTeicoplanin: an alternative drug for the" exact="treatment" post="of coronavirus COVID-19?Int J Antimicrob Agents2020105944 32[2020].Available from: https://www.fda.gov/."/>
  <result pre="a recommendation to examine the effect of hydroxychloroquine in preventing" exact="infection" post="and progressionJ Antimicrob Chemother2020 39ColsonPRolainJMLagierJCBrouquiPRaoultDChloroquine and hydroxychloroquine as available"/>
  <result pre="Antimicrob Agents2020105938 41GaoJTianZYangXBreakthrough: Chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends1412020727332074550 42GautretPLagierJ-CParolaPMeddebLMailheMDoudierBHydroxychloroquine"/>
  <result pre="pneumonia in clinical studiesBiosci Trends1412020727332074550 42GautretPLagierJ-CParolaPMeddebLMailheMDoudierBHydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
  <result pre="disease 2019: friend or Foe?Cardiol Rev285202026627132769401 44HernandezAVRomanYMPasupuletiVBarbozaJJWhiteCMHydroxychloroquine or chloroquine for" exact="treatment" post="or prophylaxis of COVID-19: a living systematic reviewAnna Intern"/>
  <result pre="randomized trials. 2020:1-12. 46ZouLDaiLZhangXZhangZZhangZHydroxychloroquine and chloroquine: a potential and controversial" exact="treatment" post="for COVID-19Arch Pharmacal Res202018 47HuTYFriemanMWolframJInsights from nanomedicine into chloroquine"/>
  <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19J Crit Care2020 49WangMCaoRZhangLYangXLiuJXuMRemdesivir and chloroquine effectively inhibit"/>
  <result pre="of the index patient who caused tertiary transmission of COVID-19" exact="infection" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
  <result pre="COVID-19 infection in Korea: the application of lopinavir/ritonavir for the" exact="treatment" post="of COVID-19 infected pneumonia monitored by quantitative RT-PCRJ Korean"/>
  <result pre="angiotensin blockadeNephron202019 67CronRQChathamWW.The rheumatologist's role in COVID-19J Rheumatol2020 68FavalliEGIngegnoliFDe LuciaOCincinelliGCimazRCaporaliRCOVID-19" exact="infection" post="and rheumatoid arthritis: Faraway, so close!Autoimmun Rev2020102523 69XuXHanMLiTSunWWangDFuBEffective treatment"/>
  <result pre="LuciaOCincinelliGCimazRCaporaliRCOVID-19 infection and rheumatoid arthritis: Faraway, so close!Autoimmun Rev2020102523 69XuXHanMLiTSunWWangDFuBEffective" exact="treatment" post="of severe COVID-19 patients with tocilizumabChinaXiv preprint2020 70DiaoBWangCTanYChenXLiuYNingLReduction and"/>
  <result pre="pathogenesis, diagnosis, and ongoing clinical trialsCureus1252020 79ErolA.High-dose intravenous vitamin C" exact="treatment" post="for COVID-19. 2020. 80WangL-sWangY-rYeD-wLiuQ-qA review of the 2019 Novel"/>
 </snippets>
</snippetsTree>
